In conclusion, in endometrial cancer, fibulin-4 acts as a tumor suppressor, and inhibits cancer cell invasion and metastasis by preventing EMT proceeding through the Wnt/ β-catenin pathway. This evidence concerns the gene EFEMP2 and cancer.